Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Progyny Inc AI / Artificial Intelligence Health care industry
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Business News Pharmaceuticals Companies
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Starbucks Corp Inflation Market Outlook
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Science Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotech and Pharmaceuticals Pharmaceuticals Breaking News: Markets
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Pfizer Inc Business News Pharmaceuticals
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Economy BE Semiconductor Industries NV Stock markets
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Science Health care industry Social issues
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health care industry LILLY DRN Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Pharmaceuticals Business News Companies
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Obesity Technology LILLY DRN
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc GE HealthCare Technologies Inc AstraZeneca PLC
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags US: News Social issues LILLY DRN
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags NVIDIA Corp Microstrategy Inc Breaking News: Investing
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy DICK'S Sporting Goods Inc Amgen Inc
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Amgen Inc Breaking news Breaking News: Business
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Business News Pharmaceuticals Companies
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Healthy Returns Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Biotech and Pharmaceuticals Healthy Returns UnitedHealth Group Inc
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags US: News LILLY DRN Breaking news
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Health & Science Novo Nordisk A/S Biotechnology
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags Politics semaglutide Ozempic
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Social issues Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Pharmaceuticals Business News Companies
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Abbott Laboratories Social issues Health & Science
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Mad Money Uranium Energy Corp U/S/ Markets
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Europe News Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Crime Business Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Market Outlook Europe Markets China Markets
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.